114027
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
水胶体敷料与液体敷料治疗危重症患者失禁相关性皮炎的临床评价
Authors Wang L, Tong M, Liu Z, Fu J, Zhu H, Guo J
Received 26 September 2025
Accepted for publication 12 December 2025
Published 23 December 2025 Volume 2025:18 Pages 3579—3587
DOI https://doi.org/10.2147/CCID.S570471
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Michela Starace
Liuliu Wang, Minghui Tong, Zeyu Liu, Junying Fu, Hongmei Zhu, Junyan Guo
Department of Nursing, Peking University International Hospital, Beijing, 100730, People’s Republic of China
Correspondence: Junyan Guo, Department of Nursing, Peking University International Hospital, NO.1of Shengming Road, Zhongguancun Life Science Park, Changping District, Beijing, 100730, People’s Republic of China, Tel +861069007372, Email junyanguo_gjypku@126.com
Objective: The aim of this study was to compare the clinical efficacy of liquid and hydrocolloid dressings in the management of incontinence-associated dermatitis (IAD) among critically ill patients and to evaluate their effects on skin lesion healing, symptom improvement, and complication prevention.
Methods: A total of 136 critically ill patients diagnosed with IAD and admitted to the hospital between January 2023 and January 2024 were included. Patients were randomly assigned using the random number table method to the hydrocolloid dressing group (n = 68) or the liquid dressing group (n = 68). The hydrocolloid dressing group received DuoDERM® hydrocolloid dressing, while the liquid dressing group received 3M™ Cavilon™ liquid dressing. Outcomes assessed included the Scoring Atopic Dermatitis (SCORAD), Dermatology Life Quality Index (DLQI), Perineal Assessment Tool (PAT) score, Visual Analogue Scale (VAS), skin lesion healing time, recurrence rate, and complications. Measurements were recorded before and after treatment, and clinical efficacy was evaluated.
Results: Following treatment, SCORAD, DLQI, PAT, and VAS scores decreased significantly in both groups compared with baseline (all p < 0.05). SCORAD, PAT, and VAS scores in the hydrocolloid dressing group were significantly lower than those in the liquid dressing group, while the DLQI scores were higher (all p < 0.05). In addition, the hydrocolloid dressing group demonstrated a shorter skin lesion healing time, lower recurrence rate, and reduced overall complication rate (all p < 0.05). The difference in clinical efficacy between the two groups was statistically significant, favoring the hydrocolloid dressing group (p < 0.05).
Conclusion: For critically ill patients with IAD, hydrocolloid dressings demonstrated superior efficacy compared with liquid dressings. Hydrocolloid dressings promoted faster healing of skin lesions, decreased recurrence and complication rates, and improved overall clinical outcomes.
Keywords: critical illness, hydrocolloids, incontinence-associated dermatitis, liquid dressing, rapid healing
Department of Nursing, Peking University International Hospital, Beijing, 100730, People’s Republic of China
Correspondence: Junyan Guo, Department of Nursing, Peking University International Hospital, NO.1of Shengming Road, Zhongguancun Life Science Park, Changping District, Beijing, 100730, People’s Republic of China, Tel +861069007372, Email junyanguo_gjypku@126.com
Objective: The aim of this study was to compare the clinical efficacy of liquid and hydrocolloid dressings in the management of incontinence-associated dermatitis (IAD) among critically ill patients and to evaluate their effects on skin lesion healing, symptom improvement, and complication prevention.
Methods: A total of 136 critically ill patients diagnosed with IAD and admitted to the hospital between January 2023 and January 2024 were included. Patients were randomly assigned using the random number table method to the hydrocolloid dressing group (n = 68) or the liquid dressing group (n = 68). The hydrocolloid dressing group received DuoDERM® hydrocolloid dressing, while the liquid dressing group received 3M™ Cavilon™ liquid dressing. Outcomes assessed included the Scoring Atopic Dermatitis (SCORAD), Dermatology Life Quality Index (DLQI), Perineal Assessment Tool (PAT) score, Visual Analogue Scale (VAS), skin lesion healing time, recurrence rate, and complications. Measurements were recorded before and after treatment, and clinical efficacy was evaluated.
Results: Following treatment, SCORAD, DLQI, PAT, and VAS scores decreased significantly in both groups compared with baseline (all p < 0.05). SCORAD, PAT, and VAS scores in the hydrocolloid dressing group were significantly lower than those in the liquid dressing group, while the DLQI scores were higher (all p < 0.05). In addition, the hydrocolloid dressing group demonstrated a shorter skin lesion healing time, lower recurrence rate, and reduced overall complication rate (all p < 0.05). The difference in clinical efficacy between the two groups was statistically significant, favoring the hydrocolloid dressing group (p < 0.05).
Conclusion: For critically ill patients with IAD, hydrocolloid dressings demonstrated superior efficacy compared with liquid dressings. Hydrocolloid dressings promoted faster healing of skin lesions, decreased recurrence and complication rates, and improved overall clinical outcomes.
Keywords: critical illness, hydrocolloids, incontinence-associated dermatitis, liquid dressing, rapid healing